1. The Marine-Derived Macrolactone Mandelalide A Is an Indirect Activator of AMPK
   Daphne R. Mattos et al, 2022, Marine Drugs CrossRef
2. Targeting the mitochondria in chronic respiratory diseases
   Dinesh Kumar Chellappan et al, 2022, Mitochondrion CrossRef
3. The role of metformin in the treatment of non-small cell lung cancer
   Jelena Ljubičić et al, 2022, Zdravstvena zaštita CrossRef
4. Tumor glycolytic profiling through 18F-FDG PET/CT predicts immune checkpoint inhibitor efficacy in advanced NSCLC
   Saulo Brito Silva et al, 2022, Ther Adv Med Oncol CrossRef
5. Low-Dose Metformin Treatment Reduces In Vitro Growth of the LL/2 Non-small Cell Lung Cancer Cell Line
   Nicole L. Stott Bond et al, 2022, Biomedicines CrossRef
6. Research progress on the therapeutic effect and mechanism of metformin for lung cancer (Review)
   Pengkai Han et al, 2022, Oncol Rep CrossRef
7. WZB117 Decorated Metformin-Carboxymethyl Chitosan Nanoparticles for Targeting Breast Cancer Metabolism
   Anindita De et al, 2023, Polymers CrossRef
8. Tumor Glycolytic Profiling Through 18F-FDG PET/CT Predicts Immune Checkpoint Inhibitor Efficacy in Advanced NSCLC
   Saulo B. Silva et al, 2022, SSRN Journal CrossRef
9. Metformin-suppressed platelet's function in vitro: Possible relation to delayed or failure of platelet-rich fibrin preparation
   Takashi Uematsu et al, 2023, Toxicology in Vitro CrossRef
10. Why Metformin Should Not Be Used as an Oxidative Phosphorylation Inhibitor in Cancer Patients
    Minas Sakellakis, 2023, Chemotherapy CrossRef
11. FFAR4 activation inhibits lung adenocarcinoma via blocking respiratory chain complex assembly associated mitochondrial metabolism
    Zhe Wang et al, 2024, Cell Mol Biol Lett CrossRef
12. Metformin Alters mRNA Expression of FOXP3, RORC, and TBX21 and Modulates Gut Microbiota in COVID-19 Patients with Type 2 Diabetes
    Pavlo Petakh et al, 2024, Viruses CrossRef
13. Gene expression of protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), solute carrier family 2 member 1 (SLC2A1) and mechanistic target of rapamycin (MTOR) in metformin-treated type 2 diabetes patients with COVID-19: impact on inflammation markers
    Pavlo Petakh et al, 2024, Inflammopharmacol CrossRef
14. NGEF is a potential prognostic biomarker and could serve as an indicator for immunotherapy and chemotherapy in lung adenocarcinoma
    Xin Chen et al, 2024, BMC Pulm Med CrossRef
15. DPEP Inhibits Cancer Cell Glucose Uptake, Glycolysis and Survival by Upregulating Tumor Suppressor TXNIP
    Qing Zhou et al, 2024, Cells CrossRef
16. Astragalus Polysaccharides and Metformin May Have Synergistic Effects on the Apoptosis and Ferroptosis of Lung Adenocarcinoma A549 Cells
    I-Yun Lee et al, 2024, CIMB CrossRef
17. Metformin Induces Resistance of Cancer Cells to the Proteasome Inhibitor Bortezomib
    Camille Schlesser et al, 2022, Biomolecules CrossRef